Go Symbol Lookup
Loading...

POSCO Denies Report Arcelor Mittal Eyeing Bid

 Text Size  
Published: Thursday, 15 Mar 2007 | 9:42 PM ET
By: Reuters

POSCO, the world's third-largest steel maker, denied a newspaper report on Friday that a senior Arcelor Mittal executive expressed interest in POSCO's M&A strategy when he visited South Korea last month.

The Korea Economic Daily said Arcelor Mittal, the world's biggest steel maker, could be interested in making a hostile takeover of South Korean steel maker POSCO.

Roland Junck, a member of Arcelor Mittal's management board, met POSCO Chief Executive Lee Ku-taek last month, but M&A issues were not discussed, the South Korean firm said at the time.

"There was no discussion on issues related to M&A when the Mittal executive met POSCO CEO last month," an official reiterated on Friday.

The official also said the company was seeking to increase the number of investors supportive to POSCO's existing strategy to ensure stable management.

 Print
Arcelor Mittal, the world's biggest steel maker, could be interested in making a hostile takeover of South Korean steel maker POSCO, the Korea Economic Daily said on Friday.

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

U.S. Video

  • Discussing the state of Detroit's economy, with CNBC Contributor Keith Boykin; Heather Higgins, Independent Women's Voice; and Doug Holtz-Eakin, American Action Forum.

  • Larry Kudlow discusses the journalistic merit of a Financial Times article, which triggered a brief sell-off in U.S markets. Larry McDonald, Newedge; Ed Butowsky, Chapwood Investments; and Ron Kruszewski, Stifel Nicolaus join in the discussion later.

  • The Supreme Court ruled today that the FTC can keep challenging "pay to delay" deals between pharmaceutical companies and generic drugmakers. CNBC Contributor Keith Boykin; Heather Higgins, Independent Women's Voice; and Doug Holtz-Eakin, American Action Forum, discuss.